Trial intelligence / Profile preview

Low-dose ketamine effects on sevoflurane MACBAR during laparoscopic cholecystectomy

ChiCTR1800018344Phase 4Recruiting

Sponsor
Affiliated Hospital of North Sichuan Medical College
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of ketamine and sevoflurane in cholecystitis and gallbladder disease (4 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoints: Heart rate and Mean arterial pressure. Started Oct 2018; status: recruiting.

02

Drugs

ketaminesevoflurane
03

Conditions

cholecystitisgallbladder disease

Beyond the preview

Go deeper on ChiCTR1800018344.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800018344.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call